Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerPolicy UpdatesClinical/Medical PolicyBluecross Idaho Reproductive Coverage Update | Ope…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifiedBluecross IdahoPolicy MP 4.02.504

    Reproductive Techniques

    Customize your policy alerts

    Sign up for Bluecross Idaho Policy MP 4.02.504 alerts

    Get alerted when Policy MP 4.02.504 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy addresses medical necessity and investigational status for selected assisted reproductive techniques, cryopreservation services, and intracytoplasmic sperm injection. Coverage remains subject to the member-specific benefit plan, applicable law, state mandates, contract limitations, and line-of-business exceptions.

    Policy Summary
    PayerBluecross Idaho
    PolicyReproductive Techniques
    Policy CodePolicy N/A
    Change TypeModified — new medically necessary cryopreservation indications
    Effective DateNov 1, 2026
    Last ReviewJul 30, 2026
    Next Review DateN/A
    Key ActionVerify the member-specific benefit plan before determining coverage.
    SourceLink
    POLICY UPDATE CHANGES

    New medically necessary indications added for oocyte and sperm cryopreservation.

    4Medically necessary technique categories
    4Investigational technique categories
    3Cryopreservation criteria required
    2New cryopreservation categories

    Medical Necessity and Investigational Status

    Medically necessary reproductive techniques

    The following reproductive techniques are considered medically necessary.

    At least one of the following

    • Blastocyst transfer
    • Adult testicular tissue cryopreservation: Cryopreservation of testicular tissue in an adult man with azoospermia as part of an intracytoplasmic sperm injection procedureAdult man with azoospermia; performed as part of an ICSI procedure
    • ICSI for male factor infertility: Intracytoplasmic sperm injection for male factor infertilityMale factor infertility
    Policy Summary
    PayerBluecross Idaho
    PolicyReproductive Techniques
    Policy CodePolicy N/A
    Change TypeModified — new medically necessary cryopreservation indications
    Effective DateNov 1, 2026
    Last ReviewJul 30, 2026
    Next Review DateN/A
    Key ActionVerify the member-specific benefit plan before determining coverage.
    SourceLink
    On This Page
    Medical Necessity and Investigational StatusBilling and Procedure CodesCoverage Conditions and Denial RisksClinical BackgroundTerms and Abbreviations

    Mature oocyte and sperm cryopreservation

    Cryopreservation of mature oocytes and sperm is considered medically necessary when all of the following criteria are met.

    All criteria required

    • Post-pubertal: The individual is post-pubertalPost-pubertal
    • Treatment-related anticipated infertility: Anticipated infertility is due to medical or surgical treatment such as gonadotoxic therapy or bilateral oophorectomyGonadotoxic therapy or bilateral oophorectomy

      Examples of gonadotoxic therapy include chemotherapy and radiation therapy.

    • Permitted cause of anticipated infertility: The anticipated infertility is not the result of normal reproductive aging or sterilization services when those services are not for treatment of an illness, injury, or diseaseNot normal reproductive aging; not non-therapeutic sterilization

    Investigational techniques

    The following reproductive techniques are considered investigational.

    Any of the following

    • Assisted hatching
    • Embryo co-culture: Co-culture of embryos
    • Prepubertal testicular tissue preservation: Cryopreservation or storage and thawing of testicular tissue in prepubertal boysPrepubertal boy
    • ICSI without male factor infertility: Intracytoplasmic sperm injection in the absence of male factor infertilityNo male factor infertility

    Cryopreservation of mature oocytes or sperm is excluded from medical necessity when anticipated infertility is due to normal reproductive aging. The policy also excludes this service when anticipated infertility results from sterilization services that are not performed to treat an illness, injury, or disease.

    Cryopreservation, storage, and thawing of testicular tissue in prepubertal boys are considered investigational under this policy.

    This policy may not apply to all lines of business. Exceptions include the Federal Employee Program, Medicare Supplement, Medicare Advantage, Medicaid, and certain self-insured groups. Coverage must be determined under the applicable member-specific benefit plan and contract.

    Mature oocyte or sperm cryopreservation is not medically necessary when anticipated infertility is caused by normal reproductive aging or by sterilization services not performed to treat an illness, injury, or disease.

    Billing and Procedure Codes

    CPTCPT
    54500Biopsy of testis, needle.
    54505Biopsy of testis, incisional (separate procedure).
    54800Biopsy of epididymis, needle.
    55400Vasovasostomy, vasovasorrhaphy.
    55870Electroejaculation.
    58321Artificial insemination; intra-cervical.
    58322Artificial insemination; intra-uterine.
    58323Sperm washing for artificial insemination.
    58970Follicle puncture for oocyte retrieval, any method.
    58974Embryo transfer, intra-uterine.
    1–10 of 37
    1/4
    HCPCSHCPCS
    S4011In vitro fertilization, including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development.
    S4013Complete cycle, gamete intrafallopian transfer (GIFT), case rate.
    S4014Complete cycle, zygote intrafallopian transfer (ZIFT), case rate.
    S4015Complete in vitro fertilization cycle, case rate.
    S4016Frozen in vitro fertilization cycle, case rate.
    S4017Incomplete cycle, treatment cancelled prior to stimulation, case rate.
    S4018Frozen embryo transfer procedure cancelled before transfer, case rate.
    S4020In vitro fertilization procedure cancelled before aspiration, case rate.
    S4021In vitro fertilization procedure cancelled after aspiration, case rate.
    S4022Assisted oocyte fertilization, case rate.
    1–10 of 14
    1/2
    Reproductive laboratory and assisted reproduction servicesCPT | HCPCS
    89354Thawing of cryopreserved reproductive tissue, testicular/ovarian
    89356Thawing of cryopreserved oocytes, each aliquot
    89398Unlisted reproductive medicine laboratory procedure
    S4011In vitro fertilization, including identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development
    S4013Complete cycle, gamete intrafallopian transfer (GIFT), case rate
    S4014Complete cycle, zygote intrafallopian transfer (ZIFT), case rate
    S4015Complete in vitro fertilization cycle, case rate
    S4016Frozen in vitro fertilization cycle, case rate
    Fertility cycle, donor, cryopreservation, and ovulation-induction servicesHCPCS
    S4017Incomplete cycle, treatment cancelled prior to stimulation, case rate
    S4018Frozen embryo transfer procedure cancelled before transfer, case rate
    S4020In vitro fertilization procedure cancelled before aspiration, case rate
    S4021In vitro fertilization procedure cancelled after aspiration, case rate
    S4022Assisted oocyte fertilization, case rate
    S4023Donor egg cycle, incomplete, case rate
    S4025Donor services for in vitro fertilization (sperm or embryo), case rate
    S4026Procurement of donor sperm from sperm bank
    S4027Storage of previously frozen embryos
    S4028Microsurgical epididymal sperm aspiration
    1–10 of 16
    1/2
    Infertility and related diagnosis codesICD-10
    N46.01-N46.9Male infertility, code range
    N73.6Female pelvic peritoneal adhesions
    N80.1-N80.9Endometriosis code range
    N97.1-N97.9Female infertility, code range
    N99.4Postprocedural pelvic peritoneal adhesions
    Testis drainage and diagnostic proceduresICD-10-PCS
    0V993ZX, 0V994ZX, 0V9B3ZX, 0V9B4ZX, 0V9C3ZX, 0V9C4ZXSurgical, drainage, testis, diagnostic, code by body part (right, left or bilateral) and approach (percutaneous, percutaneous endoscopic)
    0V9B3ZZ, 0V9C3ZZ, 0V993ZZSurgical, drainage, testis, percutaneous, code by body part (right, left or bilateral) and approach
    Testis excision and spermatic-cord drainageICD-10-PCS
    0VB93ZX, 0VB94ZX, 0VBB3ZX, 0VBB4ZX, 0VBC3ZX, 0VBC4ZXSurgical, excision, testis, diagnostic, code by body part (right, left or bilateral) and approach (percutaneous, percutaneous endoscopic)
    0V9F0ZX, 0V9F3ZX, 0V9F4ZX, 0V9G0ZX, 0V9G3ZX, 0V9G4ZX, 0V9H0ZX, 0V9H3ZX, 0V9H4ZXSurgical, drainage, spermatic cord, diagnostic, code by body part (right, left or bilateral) and approach (open, percutaneous, percutaneous endoscopic)
    Epididymal, vas deferens, and spermatic-cord drainage or excisionICD-10-PCS
    0V9J0ZX, 0V9J3ZX, 0V9J4ZX, 0V9K0ZX, 0V9K3ZX, 0V9K4ZX, 0V9L0ZX, 0V9L3ZX, 0V9L4ZXSurgical, drainage, epididymis, diagnostic, code by body part (right, left or bilateral) and approach (open, percutaneous, percutaneous endoscopic)
    0V9N0ZX, 0V9N3ZX, 0V9N4ZX, 0V9P0ZX, 0V9P3ZX, 0V9P4ZX, 0V9Q0ZX, 0V9Q3ZX, 0V9Q4ZXSurgical, drainage, vas deferens, diagnostic, code by body part (right, left or bilateral) and approach (open, percutaneous, percutaneous endoscopic)
    0VBF0ZX, 0VBF3ZX, 0VBF4ZX, 0VBG0ZX, 0VBG3ZX, 0VBG4ZX, 0VBH0ZX, 0VBH3ZX, 0VBH4ZX, 0VBJ0ZX, 0VBJ3ZX, 0VBJ4ZX, 0VBK0ZX, 0VBK3ZX, 0VBK4ZX, 0VBL0ZX, 0VBL3ZX, 0VBL4ZXSurgical, excision, spermatic cord, diagnostic, and surgical excision of epididymis, by body part and approach
    Male reproductive inspection and repair proceduresICD-10-PCS
    0VBN0ZX, 0VBN3ZX, 0VBN4ZX, 0VBP0ZX, 0VBP3ZX, 0VBP4ZX, 0VBQ0ZX, 0VBQ3ZX, 0VBQ4ZXSurgical, excision, vas deferens, diagnostic, by body part and approach
    0VJM0ZZ, 0VJR0ZZSurgical inspection of epididymis and spermatic cord, open; surgical inspection of vas deferens, open
    0VQJ0ZZ, 0VQJ3ZZ, 0VQJ4ZZ, 0VQK0ZZ, 0VQK3ZZ, 0VQK4ZZ, 0VQL0ZZ, 0VQL3ZZ, 0VQL4ZZSurgical repair of epididymis, by body part and approach
    0VQN0ZZ, 0VQN3ZZ, 0VQN4ZZ, 0VQP0ZZ, 0VQP3ZZ, 0VQP4ZZ, 0VQQ0ZZ, 0VQQ3ZZ, 0VQQ4ZZSurgical repair of vas deferens, by body part and approach
    Right vas deferens bypass proceduresICD-10-PCS
    0V1N07J, 0V1N07K, 0V1N07N, 0V1N07P, 0V1N0JJ, 0V1N0JK, 0V1N0JN, 0V1N0JP, 0V1N0KJ, 0V1N0KK, 0V1N0KN, 0V1N0KP, 0V1N0ZJ, 0V1N0ZK, 0V1N0ZN, 0V1N0ZPSurgical bypass, right vas deferens, open, with autologous tissue substitute, synthetic substitute, nonautologous tissue, or no device, by qualifier
    0V1N47J, 0V1N47K, 0V1N47N, 0V1N47P, 0V1N4JJ, 0V1N4JK, 0V1N4JN, 0V1N4JP, 0V1N4KJ, 0V1N4KK, 0V1N4KN, 0V1N4KP, 0V1N4ZJ, 0V1N4ZK, 0V1N4ZN, 0V1N4ZPSurgical bypass, right vas deferens, percutaneous endoscopic, with autologous tissue substitute, synthetic substitute, nonautologous tissue, or no device, by qualifier
    Left vas deferens bypass proceduresICD-10-PCS
    0V1P07J, 0V1P07N, 0V1P07P, 0V1P0JJ, 0V1P0JK, 0V1P0JN, 0V1P0JP, 0V1P0KJ, 0V1P0KK, 0V1P0KN, 0V1P0KP, 0V1P0ZJ, 0V1P0ZK, 0V1P0ZN, 0V1P0ZPSurgical bypass, left vas deferens, open, with autologous tissue substitute, synthetic substitute, nonautologous tissue, or no device, by qualifier
    0V1P47J, 0V1P47K, 0V1P47N, 0V1P47P, 0V1P4JJ, 0V1P4JK, 0V1P4JN, 0V1P4JP, 0V1P4KJ, 0V1P4KK, 0V1P4KN, 0V1P4KP, 0V1P4ZJ, 0V1P4ZK, 0V1P4ZN, 0V1P4ZPSurgical bypass, left vas deferens, percutaneous endoscopic, with autologous tissue substitute, synthetic substitute, nonautologous tissue, or no device, by qualifier
    Bilateral vas deferens bypass proceduresICD-10-PCS
    0V1Q07J, 0V1Q07K, 0V1Q07N, 0V1Q07P, 0V1Q0JJ, 0V1Q0JK, 0V1Q0JN, 0V1Q0JP, 0V1Q0KJ, 0V1Q0KK, 0V1Q0KN, 0V1Q0KP, 0V1Q0ZJ, 0V1Q0ZK, 0V1Q0ZN, 0V1Q0ZPSurgical bypass, bilateral vas deferens, open, with autologous tissue substitute, synthetic substitute, nonautologous tissue, or no device, by qualifier
    0V1Q47J, 0V1Q47K, 0V1Q47N, 0V1Q47P, 0V1Q4JJ, 0V1Q4JK, 0V1Q4JN, 0V1Q4JP, 0V1Q4KJ, 0V1Q4KK, 0V1Q4KN, 0V1Q4KP, 0V1Q4ZJ, 0V1Q4ZK, 0V1Q4ZN, 0V1Q4ZPSurgical bypass, bilateral vas deferens, percutaneous endoscopic, with autologous tissue substitute, synthetic substitute, nonautologous tissue, or no device, by qualifier
    Vas deferens device removal and epididymal drainageICD-10-PCS
    0VPR0DZ, 0VPR3DZ, 0VPR4DZ, 0VPR7DZ, 0VPR8DZSurgical removal of vas deferens intraluminal device, by approach
    0V9J00Z, 0V9J0ZZ, 0V9J30Z, 0V9J3ZZ, 0V9J40Z, 0V9J4ZZ, 0V9K00Z, 0V9K0ZZ, 0V9K30Z, 0V9K3ZZ, 0V9K40Z, 0V9K4ZZ, 0V9L00Z, 0V9L0ZZ, 0V9L30Z, 0V9L3ZZ, 0V9L40Z, 0V9L4ZZSurgical drainage of epididymis, by body part, approach, and drainage device or no device
    Additional male and female reproductive-system proceduresICD-10-PCS
    0VCJ0ZZ, 0VCJ3ZZ, 0VCJ4ZZ, 0VCK0ZZ, 0VCK3ZZ, 0VCK4ZZ, 0VCL0ZZ, 0VCL3ZZ, 0VCL4ZZSurgical extirpation of epididymis, by body part
    0WQM0ZZ, 0WQM3ZZ, 0WQM4ZZ, 0WQMXZZ, 0WWM07Z, 0WWM0KZ, 0WWM37Z, 0WWM3KZ, 0WWM47Z, 0WWM4KZSurgical repair of male perineum, by approach and device
    0U804ZZ, 0U814ZZ, 0U824ZZSurgical division of ovary, percutaneous endoscopic, by body part
    3E0P3LZ, 3E0P7LZ, 3E0P3Q0, 3E0P7Q0, 3E0P3Q1, 3E0P7Q1Administration and introduction into the female reproductive system of sperm or fertilized ovum, by approach and qualifier
    0WQN0ZZ, 0WQN3ZZ, 0WQN4ZZ, 0WQNXZZSurgical repair of female perineum, by approach
    8E0VX63Ob-Gyn
    Place of serviceRevenue
    Reproductive Physician OfficePlace of service associated with Ob-Gyn and reproductive physician office services
    Surgical extirpation, epididymisICD-10
    0V9L30ZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0V9L3ZZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0V9L40ZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0V9L4ZZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0VCJ0ZZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0VCJ3ZZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0VCJ4ZZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0VCK0ZZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0VCK3ZZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    0VCK4ZZSurgical, extirpation, epididymis, code by body part (right, left or bilateral)
    1–10 of 13
    1/2
    Surgical repair, male perineumICD-10
    0WQM0ZZSurgical, repair, male perineum, code by approach (open, percutaneous, percutaneous endoscopic or external)
    0WQM3ZZSurgical, repair, male perineum, code by approach (open, percutaneous, percutaneous endoscopic or external)
    0WQM4ZZSurgical, repair, male perineum, code by approach (open, percutaneous, percutaneous endoscopic or external)
    0WQMXZZSurgical, repair, male perineum, code by approach (open, percutaneous, percutaneous endoscopic or external)
    Surgical repair, male perineum, approach and deviceICD-10
    0WWM07ZSurgical, repair, male perineum, code by approach and device
    0WWM0KZSurgical, repair, male perineum, code by approach and device
    0WWM37ZSurgical, repair, male perineum, code by approach and device
    0WWM3KZSurgical, repair, male perineum, code by approach and device
    0WWM47ZSurgical, repair, male perineum, code by approach and device
    0WWM4KZSurgical, repair, male perineum, code by approach and device
    Surgical division, ovaryICD-10
    0U804ZZSurgical, division, ovary, percutaneous endoscopic, code by body part (right, left or bilateral)
    0U814ZZSurgical, division, ovary, percutaneous endoscopic, code by body part (right, left or bilateral)
    0U824ZZSurgical, division, ovary, percutaneous endoscopic, code by body part (right, left or bilateral)
    Introduction, female reproductive, spermICD-10
    3E0P3LZAdministration, physiological systems and anatomical regions, introduction, female reproductive, sperm, code by approach (percutaneous or via natural or artificial opening)
    3E0P7LZAdministration, physiological systems and anatomical regions, introduction, female reproductive, sperm, code by approach (percutaneous or via natural or artificial opening)
    Introduction, female reproductive, fertilized ovumICD-10
    3E0P3Q0Administration, physiological systems and anatomical regions, introduction, female reproductive, fertilized ovum, code by approach and qualifier
    3E0P7Q0Administration, physiological systems and anatomical regions, introduction, female reproductive, fertilized ovum, code by approach and qualifier
    3E0P3Q1Administration, physiological systems and anatomical regions, introduction, female reproductive, fertilized ovum, code by approach and qualifier
    3E0P7Q1Administration, physiological systems and anatomical regions, introduction, female reproductive, fertilized ovum, code by approach and qualifier
    Surgical repair, female perineumICD-10
    0WQN0ZZSurgical, repair, female perineum, code by approach (open, percutaneous, percutaneous endoscopic or external)
    0WQN3ZZSurgical, repair, female perineum, code by approach (open, percutaneous, percutaneous endoscopic or external)
    0WQN4ZZSurgical, repair, female perineum, code by approach (open, percutaneous, percutaneous endoscopic or external)
    0WQNXZZSurgical, repair, female perineum, code by approach (open, percutaneous, percutaneous endoscopic or external)
    Other procedure, male reproductive system, external, collection, spermICD-10
    8E0VX63Other procedure, male reproductive system, external, collection, sperm

    Coverage Conditions and Denial Risks

    Documentation Required

    Apply Member-Specific Benefit Plan Controls

    Verify member eligibility and apply the member-specific benefit plan, applicable state mandates, and related policies before determining coverage. The member-specific plan controls if it conflicts with this medical policy, and some plans specifically exclude cryopreservation or storage charges.

    • Coverage of infertility services varies by member-specific benefit plan and may be governed by state mandates.
    • Cryopreservation of mature oocytes and sperm is medically necessary only when the individual is post-pubertal, anticipated infertility is due to medical or surgical treatment such as gonadotoxic therapy or bilateral oophorectomy, and the anticipated infertility is not due to normal reproductive aging or non-illness-related sterilization.
    • Medically necessary techniques include blastocyst transfer, adult testicular-tissue cryopreservation for azoospermia when part of an intracytoplasmic sperm injection procedure, and ICSI for male-factor infertility.
    • Check the benefit plan description for contractual exclusions or limitations on cryopreservation and storage.
    Denial Risk

    Investigational Techniques

    Do not represent the following reproductive techniques as covered under this policy; they are considered investigational. ICSI is investigational when performed without male-factor infertility.

    • Assisted hatching.
    • Co-culture of embryos.
    • Cryopreservation, storage, or thawing of testicular tissue in prepubertal boys.
    • Intracytoplasmic sperm injection in the absence of male-factor infertility.
    Denial Risk

    Excluded Cryopreservation Indications

    Do not approve cryopreservation of mature oocytes or sperm when the anticipated infertility is attributable to normal reproductive aging or to sterilization services that were not performed to treat an illness, injury, or disease.

    • The individual must be post-pubertal.
    • Anticipated infertility must result from medical or surgical treatment, such as chemotherapy, radiation therapy, or bilateral oophorectomy.
    • All applicable medical-necessity criteria must be met.
    Billing Rule

    Check Contractual Limitations

    Review the member contract or certificate of coverage for exclusions, eligibility restrictions, partner-coverage rules, and benefit caps before billing or authorizing assisted reproductive techniques.

    • Eligibility after a prior voluntary sterilization procedure, including vasectomy or tubal ligation, varies by contract; reversal coverage may also be limited.
    • Procedures performed on one partner may not be payable under the other partner's infertility benefits. Workup and diagnosis for a noncovered partner may likewise be excluded.
    • Cryopreservation and storage of embryos or sperm may be limited, particularly when sperm is preserved before voluntary sterilization or when there is no specific plan for insemination or embryo implantation.
    • Contracts may impose a dollar cap on infertility benefits. Determine whether the cap includes infertility workup and diagnosis, therapy, or both.
    • A vasectomy-related diagnosis may be recorded as male-factor infertility, but coverage remains subject to the applicable contract.

    Clinical Background

    Infertility may result from female factors, male factors, combined male and female factors, or unknown causes. Assisted reproductive technologies involve handling eggs or embryos and may include in vitro fertilization, oocyte harvesting, sperm collection, laboratory fertilization or culture, cryopreservation, and transfer or implantation of the resulting embryo.

    Terms and Abbreviations

    Assisted reproductive technologies (ARTs)
    DefinitionFertility treatments in which eggs or embryos are handled.
    Common applicationAssisted reproductive technology commonly involves in vitro fertilization, in which retrieved oocytes are inseminated with sperm and the resulting embryo is transferred to the uterus or fallopian tubes.
    Not includedAssisted insemination using sperm from a woman’s partner or a sperm donor is not included in this definition.
    Infertility
    DefinitionA condition that may be caused by female factors, male factors, combined male and female factors, or unknown causes.
    Female factorsExamples include pelvic adhesions, ovarian dysfunction, endometriosis, and prior tubal ligation.
    Male factorsExamples include abnormalities in sperm production, function, or transport and prior vasectomy.
    Assisted hatching
    DefinitionMechanical disruption of the zona pellucida surrounding the developing embryo.
    PurposeThe technique is intended to facilitate escape of the developing embryo.
    Proposed benefitAssisted hatching has been proposed as a way to improve implantation after IVF.
    Assisted hatching
    Clinical roleAn adjunctive technique used with IVF and evaluated against IVF without assisted hatching.
    Reviewed approachesThe reviewed approaches included laser, chemical, and mechanical methods.
    Evidence reviewedA Cochrane review identified 31 randomized controlled trials involving 5,728 participants.
    Embryo co-culture
    DefinitionA technique intended to improve embryo culture so that a greater proportion of embryos reach the blastocyst stage.
    Intended outcomesThe intended outcomes include improved implantation and pregnancy rates.
    Embryo numberIf implantation improves, fewer embryos could be transferred in each cycle, potentially decreasing multiple pregnancies.
    Feeder cell layer
    DefinitionA cell layer used in embryo co-culture to support embryo culture.
    Human sourceFeeder cell layers may be derived from human reproductive tissues, including oviducts.
    Other sourcesOther sources include fetal bovine uterine or oviduct cells, Vero cells, and bovine kidney cells.
    Ovarian tissue cryopreservation
    DefinitionCryopreservation of ovarian tissue or an entire ovary followed by transplantation.
    TransplantationTransplantation may be autologous or heterotopic.
    PurposeThe technique is intended to sustain reproductive function threatened by sterilizing procedures such as chemotherapy, radiotherapy, or surgery.
    Vitrification
    DefinitionA flash-freezing cryopreservation process.
    ComparisonVitrification is faster than controlled-rate slow cooling.
    CryoprotectantsVitrification requires a higher concentration of cryoprotectants.
    Blastocyst-stage transfer
    DefinitionEmbryo transfer performed at the blastocyst stage.
    TimingTransfer generally occurs on day 5 or 6 after fertilization.
    Compared with cleavage-stage transferBlastocyst-stage transfer occurs later than cleavage-stage transfer, which generally occurs on day 2 or 3.
    Cleavage-stage transfer
    DefinitionEarlier embryo transfer performed at the cleavage stage.
    TimingTransfer generally occurs on day 2 or 3 after fertilization.
    Compared with blastocyst-stage transferCleavage-stage transfer occurs before blastocyst-stage transfer, which generally occurs on day 5 or 6.
    Male factor infertility (MFI)
    DefinitionA condition in which insufficient sperm numbers, abnormal sperm morphology, or poor sperm motility prevent unassisted IVF.
    Sperm quantityInsufficient sperm numbers may constitute male factor infertility.
    Sperm qualityAbnormal morphology or poor motility may constitute male factor infertility.
    Intracytoplasmic sperm injection (ICSI)
    DefinitionA procedure used in IVF for male factor infertility in which sperm is injected into an oocyte.
    IndicationICSI is used when sperm quantity, morphology, or motility precludes unassisted IVF.
    Clinical settingThe therapy reviewed is IVF with ICSI.
    Blastocyst-stage embryo transfer
    DefinitionEmbryo transfer performed at the blastocyst stage rather than at the earlier cleavage stage.
    Blastocyst timingBlastocyst-stage transfer generally occurs on day 5 or 6 after fertilization.
    Evidence comparisonThe reviewed evidence compares outcomes between blastocyst-stage and cleavage-stage transfer strategies.
    Testicular sperm extraction
    DefinitionCollection of sperm from testicular tissue in men with azoospermia.
    Timing of collectionExtraction may be performed during or after a diagnostic biopsy.
    Use of collected spermSperm may be used immediately for ICSI, or tissue and/or sperm may be cryopreserved for later ICSI cycles.
    Cryopreservation of testicular tissue
    DefinitionPreservation by freezing of testicular tissue or isolated sperm for subsequent use.
    Subsequent treatmentPreserved tissue or sperm may be used in later ICSI cycles.
    Alternative specimensEither isolated sperm or the entire tissue sample may be cryopreserved.
    Testicular sperm extraction
    PopulationTesticular sperm extraction is performed in men with azoospermia.
    Collection and useSperm is collected from testicular tissue and may be isolated immediately for ICSI.
    Later useThe tissue may instead be cryopreserved for later sperm isolation and ICSI cycles.
    Cryopreservation of testicular tissue
    DefinitionFreezing of isolated sperm or testicular tissue for later use.
    ThawingThe preserved sperm or tissue can be thawed for subsequent use.
    Treatment contextThawed material may be used during a subsequent ICSI cycle.
    Azoospermia
    DefinitionAbsence of spermatozoa in the ejaculate.
    Relevant populationThe adult population reviewed includes men with azoospermia.
    Related procedureMen with azoospermia may undergo testicular sperm extraction.
    NCT
    AbbreviationNCT.
    MeaningNational clinical trial identifier.
    Use in the policyNCT appears with clinical-trial listings and trial identifiers.
    NCT
    AbbreviationNCT.
    Expanded meaningNational clinical trial.
    Policy exampleThe clinical-trial section uses NCT with trial identifiers such as NCT03764865 and NCT04616417.
    M-A
    AbbreviationM-A.
    MeaningMeta-analysis.
    Evidence useThe abbreviation identifies evidence that statistically combines results from multiple studies.
    SR
    AbbreviationSR.
    MeaningSystematic review.
    Evidence useThe abbreviation identifies a structured review of the available evidence.